Cusnir Explores Impact of ARANOTE Data on ARPI Plus ADT Use in mHSPC
Mike Cusnir, MD Chief, Division of Hematology & Oncology Codirector, Gastrointestinal Malignancies Assistant Professor Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center New York, NY Peers & Perspectives in Oncology: What was learned from the recent phase 3 ARANOTE trial (NCT04736199) data? CUSNIR: This study was presented this year just after the data … Read more